Dotinurad Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Dotinurad is an organic compound with the chemical Name (3,5-dichloro-4-hydroxyphenyl)(1,1-dioxidobenzo[d]thiazol-3(2H)-yl)methanone. This compound is a newer urate-lowering agent that suppresses uric acid reabsorption through the selective inhibition of urate transporter 1 (URAT1) in the proximal renal tubules, and it was first approved in Japan in 2020 for the treatment of hyperuricemia, irrespective of gout[1].
Verwenden
Dotinurad is a useful drug for treating hyperuricemia and gout.
Trademarks
URECE
Synthese
Aminothiophenol (152) reacts with hydrated formaldehyde to give dihydrobenzothiazole 153. Acid chloride 155 is generated from acid 154. Dihydrobenzothiazole 153 is condensed with acid chloride 155 to form amide 156. Thiazole is oxidized using mCPBA. Methyl ether is removed in the presence of lithium chloride to give doxenolide.
Dotinurad Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte